SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-005814
Filing Date
2017-03-31
Accepted
2017-03-31 16:26:22
Documents
4
Period of Report
2017-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-KCFO bioa-8k_20170328.htm 8-K 40055
2 EX-10.1 bioa-ex101_6.htm EX-10.1 48281
3 EX-99.1 bioa-ex991_7.htm EX-99.1 9061
4 GRAPHIC g2017033119484958954423.jpg GRAPHIC 9061
  Complete submission text file 0001564590-17-005814.txt   111328
Mailing Address 3850 ANNAPOLIS LANE NORTH, SUITE 180 PLYMOUTH MN 55447-5476
Business Address 3850 ANNAPOLIS LANE NORTH, SUITE 180 PLYMOUTH MN 55447-5476 612-747-4423
BioAmber Inc. (Filer) CIK: 0001534287 (see all company filings)

IRS No.: 980601045 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35905 | Film No.: 17730735
SIC: 2860 Industrial Organic Chemicals